You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 26, 2011

Tilleke & Gibbins Names New Partners

Tilleke & Gibbins, the largest independent law firm in Thailand, proudly announces the appointment of Alan Adcock, Nandana Indananda, and Thomas J. Treutler as Partners of the firm.

Alan Adcock is known for his “detailed knowledge of the law” (The Legal 500 Asia Pacific 2010/2011), fluency in Mandarin, and outstanding client service. Alan represents diverse clients, from pioneers in the life sciences to the biggest IP owners in the world, and helps them achieve the dual goals of profit and protection in Asia. He specializes in IP acquisitions, technology transfer, IP contributions, clinical trials, IP licensing, IP enforcement, and regulatory affairs. Alan received his law degree from Columbia University and is licensed in New York and New Jersey.

Nandana Indananda served as Judge of the Central Intellectual Property and International Trade Court (2006-2008), Research Judge of the Supreme Court (Intellectual Property and International Trade Division) (2003-2006), and Judge attached to the Central Tax Court (1997-2003). A lawyer who commands the respect of colleagues, clients, and opposing parties, Nandana specializes in intellectual property, international commercial transactions, e-commerce, biotechnology, and information technology laws. He is a frequent contributor to definitive legal journals and lectures at top universities in Thailand.

Thomas J. Treutler is the managing director of Tilleke & Gibbins’ Hanoi and Ho Chi Minh City offices. Tom is fluent in Vietnamese and is registered to practice as a Foreign Lawyer in Vietnam. Tom is also licensed to practice before the United States Patent and Trademark Office and in California. Featured as a leading lawyer in Chambers Asia (2008-2010), Tom has expertise in both commercial law and IP enforcement. He has secured a number of landmark victories for foreign investors operating in the life sciences and technology sectors.

Darani Vachanavuttivong, Co-Managing Partner of Tilleke & Gibbins, says, “Alan Adcock and Nandana Indananda each add tremendous value to the firm and our IP practice. Alan brings extensive on-the-ground experience defending intellectual assets in two of the toughest jurisdictions in the world, China and Thailand, while Nandana is known for his legal acumen, honed during his decade of service on the bench.”

Tiziana Sucharitkul, Co-Managing Partner of the firm, adds, “Under Thomas J. Treutler’s leadership, our Vietnam practice is flourishing, particularly in the areas of commercial transactions and IP. All three new Partners are mentors and leaders, and they represent the bright future of our firm.”

 

RELATED INSIGHTS​ 

May 28, 2020
John Frangos, partner and deputy director of Tilleke & Gibbins’ dispute resolution department, and head of the firm’s aviation industry team, was recently interviewed about the Thai government’s decision to allow Thai Airways to enter restructuring proceedings for two articles by aviation industry data and analytics leader, Cirium.
May 21, 2020
On May 21, Chaiwat Keratisuthisathorn, counsel in Tilleke & Gibbins’ corporate and commercial group, will join a webinar entitled “Liabilities and Risks for Leaders When Dealing with a Pandemic Crisis.” The highly-anticipated webinar, hosted jointly by Tilleke & Gibbins and Marsh, is designed to assist leaders of Thai companies who may be inadvertently exposed to additional risks and liabilities while navigating the complex challenges presented by COVID-19.
May 8, 2020
On May 8, 2020, Atthachai Homhuan, manager, regulatory affairs, at Tilleke & Gibbins, was the invited speaker for a Licensing Executives Society (LES) Thailand webinar about the COVID-19 responses of the Thai Food and Drug Administration (FDA) and the Department of International Trade (DIT). He spoke about the ongoing steps the Thai FDA and DIT have taken to encourage the domestic availability of critical products for the fight against COVID-19.